CTOs on the Move

LetsGetChecked

www.letsgetchecked.com

 
LetsGetChecked is a virtual care company that allows customers to manage their health from home, providing direct access to telehealth services, pharmacy, and laboratory tests with at-home sample collection kits for a wide range of health conditions including Sexual Health, Cholesterol, Diabetes, Thyroid, Coronavirus (COVID-19), and more. Founded in 2015, the company empowers people with the care they need to live longer, happier lives. Today, LetsGetChecked is a leader in healthcare innovation with an end-to-end model including manufacturing, logistics, lab analysis, affiliated physician support, and prescription fulfillment, which provides a seamless user experience and a convenient, reliable and secure ...
  • Number of Employees: 250-1000
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Funding

LetsGetChecked raised $12M on 03/28/2018
LetsGetChecked raised $30M on 05/08/2019
LetsGetChecked raised $71M on 05/05/2020
LetsGetChecked raised $150M on 06/08/2021

Similar Companies

PerioSeal

PerioSeal is a Little Rock, AR-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

The Toiyabe Group

The Toiyabe Group is a Sparks, NV-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Medical Instrument Development Laboratories

Medical Instrument Development Laboratories is a San Leandro, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

DHD2 - District Health Department 2

District Health Department #2 is a government administration organization that provides leadership in promoting environmental and personal health through health promotion, disease detection, disease prevention, education, and regulation in hopes of a h...

Imagin Medical

Imagin Medical is developing imaging solutions for the early detection of cancer through the use of endoscopes. The Company believes it will radically improve the way physicians detect cancer. Imagin`s initial target market is bladder cancer, a major cancer worldwide, the sixth most prevalent in the U.S., and the most costly cancer to treat due to a greater than 50% recurrence rate. Developed at the Lawrence Livermore National Laboratory, this advanced, ultrasensitive imaging technology is based upon improved optical designs and advanced light sensors.